Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on August 18, 2025
Positron Emission Tomography Market to Capture a CAGR of 6.60% While Touching Approximately USD 4.44 Billion by 2034 – Report by Zion Market Research
GlobeNewswire
·
August 18, 2025
NEW YORK, USA, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Positron Emission Tomography Market By Product Type (Partial ring PET scanner, Full ring PET scanner), By Detector Type (Lutetium …
BNC Expands Holdings to 325,000 BNB, Cementing Its Role as the World’s Largest BNB Treasury
GlobeNewswire
·
August 18, 2025
New York, Monday, Aug. 18, 2025 (GLOBE NEWSWIRE) -- BNB Network Company (Nasdaq: BNC), the treasury management business of CEA Industries Inc., today announced another major milestone in its treasury strategy, with total holdings now reaching 325,000 BNB, …
Genius Group Provides Update on Legal Cases
GlobeNewswire
·
August 18, 2025
SINGAPORE, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, has scheduled a Live Spaces call on X.com at 9.00am Eastern Time, August 26, 2025 …
Journey Medical Corporation to Present at the Emerging Growth Conference
GlobeNewswire
·
August 18, 2025
SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company primarily focused on selling and marketing FDA-approved …
Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
GlobeNewswire
·
August 18, 2025
August 18, 2025 Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Opportunity to be First Mover in $7.3Bn Addressable Market Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), ( …
Houston American Energy Corp. enters their next stage of development with the appointment of best in industry Engineering and Service Provider
GlobeNewswire
·
August 18, 2025
Climate change Industry leaders in environmental infrastructure delivery HOUSTON, TX, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Houston American Energy Corp. (NYSE American: HUSA) (“HUSA” or the “Company”) and Abundia Global Impact Group (AGIG), announced the …
HeartCore’s Go IPO Client, rYojbaba Co., Ltd., Begins Trading on the Nasdaq Stock Market
GlobeNewswire
·
August 18, 2025
NEW YORK and TOKYO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, announced its Go IPO client, rYojbaba Co., Ltd. …
Advent Technologies and Stralis announce Pioneering Relationship to Advance Hydrogen Electric Flight
GlobeNewswire
·
August 18, 2025
LIVERMORE, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN) an innovation-driven leader in the fuel cell and hydrogen technology sector, is supplying its proprietary membrane electrode assembly technology to …
Quoin Pharmaceuticals Appoints New Chief Financial Officer to Support Commercialization Strategy
GlobeNewswire
·
August 18, 2025
ASHBURN, Va., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today announced the appointment of its new …
Myriad Genetics Appoints Ben Wheeler Chief Financial Officer
GlobeNewswire
·
August 18, 2025
SALT LAKE CITY, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Ben Wheeler has been promoted to Chief Financial Officer, effective August 16, …
Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue
GlobeNewswire
·
August 18, 2025
HOUSTON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBO) is pleased to announce that the US Patent and Trademark Office has issued U.S. patent No. 12,357,584 B2 entitled “Composition and Method of Controlling Infectious Diseases with …
HireRoad’s Acendre Recruit Achieves PROTECTED Classification Through Independent IRAP Assessment
EIN Presswire
·
August 18, 2025
MELBOURNE, AUSTRALIA, August 17, 2025 /EINPresswire.com/ -- HireRoad today announced that Acendre Recruit, its flagship recruitment platform purpose-built for government, has successfully completed an independent assessment under the Australian …
VivoPower’s Tembo e-LV Subsidiary on Track for $200 Million Enterprise Value Investment from Energi Holdings via SPAC Transaction
GlobeNewswire
·
August 18, 2025
Energi to acquire 51% of Tembo with VivoPower continuing to hold a significant shareholding in Tembo post-SPAC merger Energi is supportive of Tembo’s business combination with Cactus Acquisition Corp 1 Limited (“SPAC”) at an equity valuation of $838 …
Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.
GlobeNewswire
·
August 18, 2025
Press Release Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S. Baar, Switzerland; August 14, 2025 …
Ocean Power Technologies Expands U.S. Presence with New Washington, D.C. Office at AUVSI Headquarters
GlobeNewswire
·
August 18, 2025
MONROE TOWNSHIP, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative, low-carbon offshore power, data, and service solutions, today announced the opening of a new …
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 18, 2025
NRx Drug Development Grant of expanded Fast Track Designation for NRX-100 from the FDA for all indications and types of depression and related disorders based on its potential to satisfy an unmet medical need. Represents an approximately 10-fold expansion …
Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases
GlobeNewswire
·
August 18, 2025
· Collaboration strengthens Boehringer’s pipeline in Eye Health. · Many patients with diabetic retinopathy (DR) continue to experience vision loss or treatment fatigue, underscoring an unmet need. · Melanocortin receptor agonists offer …
AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority
GlobeNewswire
·
August 18, 2025
In the largest real-world study of its kind with 428,707 patients, the Zio LTCM service outperformed other studied monitoring approaches in cardiac arrhythmia diagnostic yield, time to diagnosis, cardiovascular events, and total health care costs. Findings …
FTC Solar to Participate in Upcoming Investor Events
GlobeNewswire
·
August 18, 2025
AUSTIN, Texas, Aug. 18, 2025 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software and engineering services, announced today that members of its management team are scheduled to participate in meetings …
SUNation Energy Announces 2025 Second Quarter Results and Reiterates Full Year Financial Guidance
GlobeNewswire
·
August 18, 2025
FY 2025 Total Sales Expected to Rise 14% - 23% from FY 2024 with Positive Adjusted EBITDA Q2 2025 Select Highlights Gross Margin Expanded to 37% Total Debt Declined by $11.7 Million, a 61% Improvement from December 31, 2024 Residential Backlog at June 30, …